Vol 15, No 2 (April 30, 2024): Journal of Gastrointestinal Oncology

Original Article

Computer-aided diagnostic system with automated deep learning method based on the AutoGluon framework improved the diagnostic accuracy of early esophageal cancer
Xin Gao, Jiaxi Lin, Changju Qu, Chao Wang, Airong Wu, Jinzhou Zhu, Chunfang Xu
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:535-543
.
Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases
Justin A. Drake, Andrew J. Sinnamon, Samir Saeed, Rutika Mehta, Russell F. Palm, Jobelle J. Baldonado, Jacques P. Fontaine, Jose M. Pimiento
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:544-554
.
Effect of perioperative blood transfusion on complications and prognosis after radical gastrectomy in elderly patients: a retrospective study of 1,666 cases
Jinqiang Liu, Kunli Du, Rui Zhang, Wei Zhou, Gaozan Zheng, Pengfei Wang, Jianyong Zheng, Fan Feng
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:555-565
.
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer
Xiaoqian Ma, Wenjuan Xu, Lingyu Qi, Qian Zhang, Xiujing Sun, Shutian Zhang
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:566-576
.
Contribution of genetic polymorphism in ABCB1 to individual variations of imatinib plasma levels in patients with gastrointestinal stromal tumor
Yinggang Ge, Huili Bai, Alessandro Mazzocca, Jun Zhang, Ziwei Wang, Xingye Wu
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:577-584
.
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study
Yulu Fang, Yifan Zhao, Xiaofu Yu, Shuxun Liu, Gang Tao, Haijun Zhong, Hai Xiang, Yunshan Yang, Zhong Shi
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:585-596
.
The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database
Yang Shen, Shuhong Yu, Yuefeng Zhang, Siyu Wang, Jiayu Chen, Yangtao Xu, Xinyao Hu, Jiayi Li, Shan Jiang, Ling Wang, Le Xu, Zhuolin Zhou, Junjian Deng, Biao Chen, Ximing Xu
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:597-611
.
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
Rong-Rong Li, Hui-Jun Zhou, De-Yu Zeng, Shao-Feng Jiang, Wu Liu, Petter Frühling, Zhen-Yang Liu
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:612-629
.
Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study
Jialong Tao, Yingtian Zhang, Yanjie Wang, Sijia Huang, Wenwen Gao, Liya Dai, Zhengyang Feng, Chenchen Jiao, Yusong Zhang
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:630-640
.
High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma
Zhe Sun, Haodi Wang, Yao Xu, Yichi Liu, Lu Wang, Ruijie Zhou, Runlong Zhou, Wenjian Ma, Tongcun Zhang
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:641-667
.
Construction and validation of a nomogram for predicting disease-free survival after radical resection of rectal cancer using perioperative inflammatory indicators
Jiayi Sun, Xinzhi Zhong, Xiangqi Yin, Huimin Wu, Lei Li, Ruiling Yang
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:668-680
.
Survival in metastatic microsatellite-stable colorectal cancer correlated with tumor mutation burden and mutations identified by next-generation sequencing
Nicholas Taflin, Lyndsey Sandow, Rajat Thawani, Shangyuan Ye, Adel Kardosh, Christopher L. Corless, Emerson Y. Chen
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:681-688
.
Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis
Linhui Zhu, Xuan Ye, Youjun She, Wensheng Liu, Kiyoshi Hasegawa, Roberta Elisa Rossi, Qiong Du, Qing Zhai
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:689-709
.
Efficacy and safety analysis of selective hepatic vein occlusion combined with arterial chemoembolization versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
Jiang Chang, Haochen Wang, Jian Li, Long Jin
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:710-720
.
Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes
Phan Nhan Hien, Ho Jong Chun, Jung Suk Oh, Su Ho Kim, Byung Gil Choi
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:721-729
.
Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity
Meng Wang, Lin Liu, Xinze Li, Wenna Jiang, Jiawei Xiao, Qianhui Hao, Jiayi Wang, Abhinav V. Reddy, Alice Talbot, Shinichi Ikuta, Derun Tian, Li Ren
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:730-746
.
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study
Minghao Zhang, Nana Li, Kuanjie Ma, Lin Wang, Yurong Cai, Zhen Liu
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:747-754
.
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank
Emmy Borgmästars, Sara Jacobson, Maja Simm, Mattias Johansson, Ola Billing, Christina Lundin, Hanna Nyström, Daniel Öhlund, Zelmina Lubovac-Pilav, Pär Jonsson, Oskar Franklin, Malin Sund
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:755-767
.
PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series
Jeremy D. Ward, Mark Fowler, Ariannette Robledo-Gomez, Shaun M. Goodyear, Adel Kardosh, Eizaburo Sasatomi
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:768-779
.

Case Series

Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series
Wendi Kang, Hongjiang Fu, Yingen Luo, Danielle M. Noreika, Tianhao Cong, Hang Li, Zhengqiang Yang
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:780-787
.

Case Report

Treatment of BRAF V600E mutant gastrointestinal stromal tumor with dabrafenib: a case report
Sonia Gowda, Lyndsey Sandow, Michael C. Heinrich
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:788-793
.
Transarterial chemoembolization for omental vein tumor thrombosis in hepatocellular carcinoma: a case report
Phan Nhan Hien, Ho Jong Chun, Su Ho Kim
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:794-799
.

Editorial Commentary

The emerging role of intra-tumoral bacteria
Giovanni Brandi, Giorgio Frega
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:800-802
.

Letter to the Editor

A description of the correction of data error and the direction of in-depth research
Jian Xiong, Weiling Yin, Xilin Du, Zhonghua Luo
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:803-804
.
Is brachial artery approach safe for hepatic artery infusion chemotherapy?
Yunlong Dai, Chang Yu, Qingbo Feng
Journal of Gastrointestinal Oncology  
2024;
15
(2)
:805-806
.